Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Anaptysbio Inc (ANAB)

18.67   -0.37 (-1.94%) 06-04 16:00
Open: 18.94 Pre. Close: 19.04
High: 19.53 Low: 18.29
Volume: 417,109 Market Cap: 509M
AnaptysBio Inc is a biotechnology company. The Company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.538 - 19.67 19.67 - 19.779
Low: 18.049 - 18.171 18.171 - 18.273
Close: 18.488 - 18.69 18.69 - 18.857

Technical analysis

as of: 2020-06-04 4:28:37 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 24.89     One year: 29.07
Support: Support1: 16.83    Support2: 14.06
Resistance: Resistance1: 21.31    Resistance2: 24.89
Pivot: 19.29
Moving Average: MA(5): 19.31     MA(20): 19.19
MA(100): 16.08     MA(250): 28.94
MACD: MACD(12,26): 0.66     Signal(9): 0.83
Stochastic oscillator: %K(14,3): 48.40     %D(3): 55.62
RSI: RSI(14): 51.00
52-week: High: 76.86  Low: 10.00  Change(%): -75.4
Average Vol(K): 3-Month: 48513  10-Days: 38832

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ANAB has closed above bottom band by 22.9%. Bollinger Bands are 36.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 06 May 2020
AnaptysBio Announces First Quarter 2020 Financial Results and Provides Pipeline Updates - GlobeNewswire

Thu, 21 May 2020
ANAB DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds AnaptysBio, Inc. Shareholders with Losses in Excess of $100000 of Class Action and Lead Plaintiff Deadline: May 26, 2020 - Business Wire

Fri, 22 May 2020
ANAB FINAL DEADLINE TUESDAY: ROSEN, A TOP RANKED INVESTOR FIRM, Reminds AnaptysBio, Inc. Investors of Important May 26 Deadline in Securities Class Action - Business Wire

Thu, 04 Jun 2020
Is It Crazy To Buy AnaptysBio Inc. (NASDAQ:ANAB) And Avis Budget Group Inc. (NASDAQ:CAR) - State Reviewer

Fri, 08 May 2020
Earnings Update: AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Mon, 25 May 2020
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27
Shares Float (M) 16
% Held by Insiders 1.59
% Held by Institutions 104.79
Shares Short (K) 6,110
Shares Short P. Month (K) 6,220

Stock Financials

EPS -3.080
EPS Est This Year -1.990
EPS Est Next Year -3.060
Book Value (p.s.) 14.690
Profit Margin
Operating Margin -403.97
Return on Assets (ttm) -12.6
Return on Equity (ttm) -19.2
Qtrly Rev. Growth
Gross Profit (p.s.) -3.348
Sales Per Share 0.843
EBITDA (p.s.) -3.386
Qtrly Earnings Growth
Operating Cash Flow (M) -69
Levered Free Cash Flow (M) -44

Stock Valuations

PE Ratio -6.06
PEG Ratio
Price to Book value 1.27
Price to Sales 22.14
Price to Cash Flow -7.43

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.